My research is focused on decision analysis of common clinical scenarios in genitourinary cancers, in particular the screening and treatment of prostate cancer. I am currently constructing a decision analytic model of screening strategies for prostate cancer based on primary data obtained from the European Randomised Study of Screening for Prostate Cancer, and collaborators in Orebro, Sweden. I also focus on treatment options for clinically localized, low-risk prostate cancer. I have recently completed a cost-effectiveness analysis of treatment strategies for low risk prostate cancer that is being used by the Employers Action Coalition on Healthcare (EACH), a group consisting of employers, payers, and providers committed to using the results generated by this model for policy decisions. This work has been presented at ASCOâ€™s Genitourinary Cancers Symposium and in a moderated poster session at ASCOâ€™s Annual Meeting. A completed effectiveness analysis of treatment options for low-risk prostate cancer has just been published.